NCL Method GTA-6
HepG2 Hepatocarcinoma Apoptosis Assay
Listed in Datasets | publication by group NCL Protocols
Version 2.0 - published on 09 Jul 2020 doi:10.17917/3F7T-M688 - cite this
Licensed under these terms
Description
This protocol describes the monitoring of nanoparticle treated human hepatocarcinoma cells (HepG2) for apoptosis, as part of the in vitro NCL preclinical characterization cascade. The protocol utilizes a fluorescent method to determine the degree of caspase-3 activation.
Content List
NCL_Method_GTA-6.pdf(PDF | 704 KB)
Cite this work
Researchers should cite this work as follows:
- Stephan Stern, Timothy Potter (2020). NCL Method GTA-6. (Version 2.0). NCI Hub. doi:10.17917/3F7T-M688
Tags
Relation to series
The publication is part of the series below:
-
TestData
A test for making a database into a publication
-
TestData
A test for making a database into a publication
-
Test Publication 2
test
-
Test Publication 2
test
-
Test Database DOI
Abstract
NCL Protocols
This publication belongs to the NCL Protocols group.
When watching a publication, you will be notified when a new version is released.